Monoclonal Mouse anti‑Human CENTG2 / AGAP1 Antibody (clone OTI4E8, Carrier‑free, IHC, WB) LS‑C786814
Monoclonal Mouse anti‑Human CENTG2 / AGAP1 Antibody (clone OTI4E8, Carrier‑free, IHC, WB) LS‑C786814
Antibody:
CENTG2 / AGAP1 Mouse anti-Human Monoclonal (Carrier-free) (OTI4E8) Antibody
Application:
IHC, WB, Flo
Format:
Unconjugated, Carrier-free
Overview
Antibody:
CENTG2 / AGAP1 Mouse anti-Human Monoclonal (Carrier-free) (OTI4E8) Antibody
Application:
IHC, WB, Flo
Format:
Unconjugated, Carrier-free
Specifications
Description
AGAP1 antibody LS-C786814 is an unconjugated mouse monoclonal antibody to human AGAP1 (CENTG2). Validated for Flow, IHC and WB.
Target
Human CENTG2 / AGAP1
Synonyms
AGAP1 | AGAP-1 | Centaurin, gamma 2 | CENTG2 | Cnt-g2 | KIAA1099 | GGAP1 | Centaurin-gamma-2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Full length human recombinant protein of human AGAP1(NP_055729) produced in HEK293T cell.
Applications
- IHC (1:150)
- Western blot (1:2000)
- Flow Cytometry (1:100)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/18/2025